![Cyrille Yann Nicolas Petit](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cyrille Yann Nicolas Petit
Directeur/Membre du Conseil chez
EUROMEDICA S.A.
Fortune : 5 295 $ au 31/01/2026
Profil
Cyrille Yann Nicolas Petit is currently Chairman at Cyrille Petit Conseil SAS; Director at Blue Earth Therapeutics Ltd., Euromedica SA, Blue Earth Diagnostics Ltd., Bracco Horizons Ltd., and Virbac SA (Independent Director since 2020); Non-Executive Director at Polarean Imaging Plc since 2020; and Manager at Happy Family SCI.
Former positions include Director at Flowonix Medical, Inc., Reapplix A, Blue Earth Diagnostics, Inc., Bioventus LLC, Bioventus, Inc.; Director-Business Development at GE Capital Americas and GE Healthcare, Inc.; Mergers & Acquisitions Analyst at BNP Paribas (New York Branch); Chief Corporate Development Officer at Smith & Nephew plc from 2012 to 2018; General Manager-Global Business Development at GE Transportation; and Principal at Goldman Sachs Ltd. Education includes undergraduate studies at École des Hautes Études Commerciales de Paris.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
POLAREAN IMAGING PLC 0,41 % | 31/12/2024 | 4 948 834 ( 0,41 % ) | 5 295 $ | 31/01/2026 |
Postes actifs de Cyrille Yann Nicolas Petit
| Sociétés | Poste | Début |
|---|---|---|
| VIRBAC | Directeur/Membre du Conseil | 18/06/2019 |
| POLAREAN IMAGING PLC | Directeur/Membre du Conseil | 01/06/2020 |
| EUROMEDICA S.A. | Directeur/Membre du Conseil | - |
Happy Family SCI
 Happy Family SCI Real Estate DevelopmentFinance Engages in rental of land and other real estate | Corporate Officer/Principal | - |
Bracco Horizons Ltd.
 Bracco Horizons Ltd. BiotechnologyHealth Technology Engages in research and development of biotechnology products | Directeur/Membre du Conseil | 31/07/2019 |
Blue Earth Diagnostics Ltd.
 Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Develops and commercialization molecular imaging technologies | Directeur/Membre du Conseil | - |
Cyrille Petit Conseil SAS | Président | - |
Blue Earth Therapeutics Ltd.
 Blue Earth Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops radiopharmaceuticals and oncology drugs | Directeur/Membre du Conseil | - |
Anciens postes connus de Cyrille Yann Nicolas Petit
| Sociétés | Poste | Fin |
|---|---|---|
| SMITH & NEPHEW PLC | Corporate Officer/Principal | 01/08/2018 |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░ ░░░░░░░ ░░░░ ░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Cyrille Yann Nicolas Petit
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
BNP Paribas (New York Branch)
 BNP Paribas (New York Branch) Regional BanksFinance Operates as a commercial bank | Finance |
Smith & Nephew plc
 Smith & Nephew plc Medical SpecialtiesHealth Technology Develops, manufactures and markets medical technology devices | Health Technology |
Flowonix Medical, Inc.
 Flowonix Medical, Inc. Medical SpecialtiesHealth Technology Designs and develops proprietary implantable pumps | Health Technology |
Virbac SA
 Virbac SA BiotechnologyHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Euromedica SA
 Euromedica SA Medical/Nursing ServicesHealth Services Provides diagnostic and primary care services | Health Services |
GE Transportation
 GE Transportation Wholesale DistributorsDistribution Services Supplies surface transportation products and services | Distribution Services |
Goldman Sachs Ltd.
 Goldman Sachs Ltd. Regional BanksFinance International merchant banking business. | Finance |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reapplix A/S
 Reapplix A/S Medical SpecialtiesHealth Technology Manufactures wound healing patches made from patient's blood that for the biological treatment and management of diabetic foot ulcers | Health Technology |
GE Capital Americas
 GE Capital Americas Financial ConglomeratesFinance Provides financial services | Finance |
Bioventus LLC
 Bioventus LLC Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
GE Healthcare, Inc.
 GE Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and retails diagnostic imaging & medical equipment | Health Technology |
Blue Earth Diagnostics Ltd.
Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Develops and commercialization molecular imaging technologies | Health Services |
Bioventus, Inc.
 Bioventus, Inc. Medical SpecialtiesHealth Technology Develops and markets medical devices for healing process | Health Technology |
Polarean Imaging Plc
 Polarean Imaging Plc Medical SpecialtiesHealth Technology Designs, manufactures and sells noble gas polarizer devices & ancillary instruments | Health Technology |
Blue Earth Diagnostics, Inc.
 Blue Earth Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Bracco SpA, Blue Earth Diagnostics, Inc. is a company that specializes in Axumin® (fluciclovine F 18) injection, an FDA-approved PET imaging radiopharmaceutical designed to detect and localize suspected recurrent prostate cancer in men with elevated prostate-specific antigen (PSA) levels following prior treatment such as prostatectomy or radiotherapy. The company is based in Burlington, MA. Axumin targets upregulated amino acid transporters in prostate cancer cells, enabling improved visualization of recurrent disease with limited urinary excretion, which aids lesion delineation near the bladder. The company provides support resources including prescribing information, clinical guidelines, reimbursement assistance, imaging center locators, and educational materials to facilitate access and appropriate use. Safety considerations include potential image interpretation challenges, rare hypersensitivity reactions, radiation exposure risks, and uncommon adverse effects such as injection site pain, erythema, and dysgeusia. | Commercial Services |
Happy Family SCI
Happy Family SCI Real Estate DevelopmentFinance Engages in rental of land and other real estate | Finance |
Cyrille Petit Conseil SAS | |
Bracco Horizons Ltd.
Bracco Horizons Ltd. BiotechnologyHealth Technology Engages in research and development of biotechnology products | Health Technology |
Blue Earth Therapeutics Ltd.
Blue Earth Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops radiopharmaceuticals and oncology drugs | Health Technology |
